OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis
Celeste M. Boesjes, Esmé Kamphuis, Marlies de Graaf, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 10, pp. 1044-1044
Closed Access | Times Cited: 5
Celeste M. Boesjes, Esmé Kamphuis, Marlies de Graaf, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 10, pp. 1044-1044
Closed Access | Times Cited: 5
Showing 5 citing articles:
Atopic dermatitis
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 3
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 3
Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data from the PROSE Registry
Neal Bhatia, Charles Lynde, Luz Fonacier, et al.
Dermatology and Therapy (2025)
Open Access
Neal Bhatia, Charles Lynde, Luz Fonacier, et al.
Dermatology and Therapy (2025)
Open Access
Five‐year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real‐world study
Luigi Gargiulo, Silvia Ferrucci, Luciano Ibba, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
Luigi Gargiulo, Silvia Ferrucci, Luciano Ibba, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
Francesca Barei, Paolo Calzari, Luca Valtellini, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
Francesca Barei, Paolo Calzari, Luca Valtellini, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
Real‐World Experience of 3‐Year Treatment With Dupilumab: Significant Decrease in Circulating Neutrophils and Eosinophils in Japanese Patients With Atopic Dermatitis
Hideyuki Nakajima, Masahiro Kamata, Yoshiki Okada, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 11
Closed Access | Times Cited: 1
Hideyuki Nakajima, Masahiro Kamata, Yoshiki Okada, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 11
Closed Access | Times Cited: 1
